File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: A comparison of intralesional triamcinolone acetonide injection for primary chalazion in children and adults

TitleA comparison of intralesional triamcinolone acetonide injection for primary chalazion in children and adults
Authors
Issue Date2014
Citation
Scientific World Journal, 2014, v. 2014, p. 413729-413729 How to Cite?
AbstractPURPOSE: To investigate outcome differences of intralesional triamcinolone acetonide (TA) injection for primary chalazia in children versus adults. METHODS: A retrospective review of consecutive subjects with primary chalazion who received intralesional TA injection was conducted. A single investigator injected 0.05-0.15 mL of TA (40 mg/mL) intralesionally. Patients were stratified into the pediatric (<18 years old) and adult (>/= 18 years old) group. In both groups, the correlation of resolution time with chalazion size and TA dose was performed. RESULTS: 17 children and 24 adults were enrolled, with a mean age of 7.4 +/- 5.5 and 39.3 +/- 16.7 years, respectively. Both groups had statistically similar baseline characteristics. There was no significant difference between the resolution time in the pediatric (18.2 +/- 11.4 days) and adult (16.5 +/- 11.0 days) group (P = 0.7). There were no significant complications from the TA injection. There was no significant correlation of resolution time to chalazion size (P = 0.7) nor TA dose (P = 0.3) in both groups. CONCLUSION: TA for the treatment of primary chalazion was equally effective in children and adults, without any significant complications, and the rate of clinical response did not appear to be dose-dependent.
Persistent Identifierhttp://hdl.handle.net/10722/208482
ISSN
2013 Impact Factor: 1.219
2015 SCImago Journal Rankings: 0.315
PubMed Central ID

 

DC FieldValueLanguage
dc.contributor.authorLee, WYJen_US
dc.contributor.authorYau, GSen_US
dc.contributor.authorWong, MYen_US
dc.contributor.authorYuen, CYen_US
dc.date.accessioned2015-03-11T07:06:18Z-
dc.date.available2015-03-11T07:06:18Z-
dc.date.issued2014en_US
dc.identifier.citationScientific World Journal, 2014, v. 2014, p. 413729-413729en_US
dc.identifier.issn1537-744Xen_US
dc.identifier.urihttp://hdl.handle.net/10722/208482-
dc.description.abstractPURPOSE: To investigate outcome differences of intralesional triamcinolone acetonide (TA) injection for primary chalazia in children versus adults. METHODS: A retrospective review of consecutive subjects with primary chalazion who received intralesional TA injection was conducted. A single investigator injected 0.05-0.15 mL of TA (40 mg/mL) intralesionally. Patients were stratified into the pediatric (<18 years old) and adult (>/= 18 years old) group. In both groups, the correlation of resolution time with chalazion size and TA dose was performed. RESULTS: 17 children and 24 adults were enrolled, with a mean age of 7.4 +/- 5.5 and 39.3 +/- 16.7 years, respectively. Both groups had statistically similar baseline characteristics. There was no significant difference between the resolution time in the pediatric (18.2 +/- 11.4 days) and adult (16.5 +/- 11.0 days) group (P = 0.7). There were no significant complications from the TA injection. There was no significant correlation of resolution time to chalazion size (P = 0.7) nor TA dose (P = 0.3) in both groups. CONCLUSION: TA for the treatment of primary chalazion was equally effective in children and adults, without any significant complications, and the rate of clinical response did not appear to be dose-dependent.en_US
dc.languageengen_US
dc.relation.ispartofScientific World Journalen_US
dc.titleA comparison of intralesional triamcinolone acetonide injection for primary chalazion in children and adultsen_US
dc.typeArticleen_US
dc.identifier.emailLee, WYJ: jackylee@hku.hken_US
dc.identifier.authorityLee, WYJ=rp01498en_US
dc.identifier.doi10.1155/2014/413729en_US
dc.identifier.pmid25386597-
dc.identifier.pmcid4214096-
dc.identifier.scopuseid_2-s2.0-84908320722-
dc.identifier.volume2014en_US
dc.identifier.spage413729en_US
dc.identifier.epage413729en_US

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats